A study analyzed CIN in a microarray dataset of lymph node-negative primary breast cancer patients prior to systemic therapy and found that ER-negative, triple-negative, and basal-like tumors have significantly higher CIN scores [29] which is correlated with tumor metastasis [27]. This evidence concerns the gene ESR1 and breast cancer.